Strategie terapeutiche antiretrovirali per il contenimento del rischio di trasmissione dell'infezione da HIV per via verticale

Translated title of the contribution: Antiretroviral treatment for reducing perinatal HIV-1 transmission

A. Maccabruni, I. Pacati, L. Arlandi, D. Caselli, M. F. Ravagni Probizer, E. Cattaneo

Research output: Contribution to journalArticle

Abstract

Objectives: To evaluate the efficacy and tolerance of different protocols of antiretroviral therapy in HIV-infected pregnant women. Patients and methods: From 1994 to 1997 44 HIV-infected pregnant women were followed in the Institute of Infectious Diseases of Pavia. 22 of them were treated with AZT only, while 3 received two nucleoside inhibitors of reverse transcriptase with or without one protease inhibitor. AZT was also administered to 19 newborns during the first 4-6 weeks of life. Results: The most common adverse effect of antiretroviral therapy was mild anaemia, occurring in 18% of women. Only one patient, treated with AZT monotherapy, transmitted the HIV infection to her newborn. Conclusions: More and more frequently the HIV pregnant women will need to begin or to continue the combination antiretroviral therapy with drugs different than AZT. The need of clear guidelines relating to the most appropriate approach in pregnancy and subsequent management of the newborn and of the mother is highlighted.

Translated title of the contributionAntiretroviral treatment for reducing perinatal HIV-1 transmission
Original languageItalian
Pages (from-to)83-89
Number of pages7
JournalGiornale Italiano di Malattie Infettive
Volume5
Issue number2
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Antiretroviral treatment for reducing perinatal HIV-1 transmission'. Together they form a unique fingerprint.

  • Cite this

    Maccabruni, A., Pacati, I., Arlandi, L., Caselli, D., Ravagni Probizer, M. F., & Cattaneo, E. (1999). Strategie terapeutiche antiretrovirali per il contenimento del rischio di trasmissione dell'infezione da HIV per via verticale. Giornale Italiano di Malattie Infettive, 5(2), 83-89.